VAGELOS P ROY - 25 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Issuer symbol
REGN
Transactions as of
25 Aug 2021
Net transactions value
-$19,455,564
Form type
4
Filing time
27 Aug 2021, 16:01:40 UTC
Previous filing
19 Aug 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $13,434,750 +75,000 +26% $179.13* 366,090 25 Aug 2021 Direct
transaction REGN Common Stock Tax liability $32,890,314 -49,282 -13% $667.39 316,808 25 Aug 2021 Direct
holding REGN Common Stock 2,218 25 Aug 2021 By 401(k) Plan
holding REGN Common Stock 141,977 25 Aug 2021 by CLAT
holding REGN Common Stock 37,747 25 Aug 2021 by Spouse as Trustee
holding REGN Common Stock 3,609 25 Aug 2021 by trust for grandch F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -75,000 -50% $0.000000 75,000 25 Aug 2021 Common Stock 75,000 $179.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.